United States · FDA National Drug Code directory
FUROSEMIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51662-1226_54f18651-515e-a0b0-e063-6394a90a5d2d
- Product NDC
- 51662-1226
- Form
- INJECTION, SOLUTION
- Composition / generic term
- FUROSEMIDE
- Labeler
- HF Acquisition Co LLC, DBA HealthFirst
- Marketing category
- NDA
- Marketing start / end (source format)
- 20180914
- Source listing expiry
- 20271231
Source-listed ingredients
- FUROSEMIDE — 10 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 mL in 1 VIAL, SINGLE-USE (51662-1226-1) · 51662-1226-1
- 25 POUCH in 1 CASE (51662-1226-3) / 1 VIAL, SINGLE-USE in 1 POUCH (51662-1226-2) / 10 mL in 1 VIAL, SINGLE-USE · 51662-1226-3
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →